Improving Diabetes Equity and Advancing Care Study
Status unconfirmed · Not applicable
Conditions studied: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
In brief
The goal of this randomized trial is to determine the optimal combination and sequence of three enhancements for a team-based care model for patients living with diabetes in Chicago. The study aim is to determine optimization of intervention components. Participants will be randomly assigned to diabetes self-management training or remote glucose monitoring. After 6 months, participants will be rerandomized to a subsequent study arm (including a CHW support program) depending on a tailoring variable of change in A1c. Researchers will compare the final 6 study arms to see which combination and sequence of enhancements produces the most improvement in A1c.
Key facts
- Study ID
- NCT06040463
- Run by
- Sinai Health System
- People needed
- 270
- Starts
- 2023-10-23
- Expected to finish
- 2025-03-31
- Last updated by the study team
- 2023-12-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- A diagnosis of type 1 or type 2 diabetes
- 18+ years of age
- Able to provide consent
- Identify as African American/Black or Latinx
- most recent HbA1c > 7%,
- Have a smartphone compatible with the Glooko application
- Have completed at least one Center appointment (i.e. current patient)
- Completed at least 3 months of their assigned study condition
You may not qualify if…
- Already an active user of RGM
- Actively working with a CHW
- Diagnosis of gestational diabetes (without type 1 or type 2)
- Has a Power of Attorney
- Be suffering from Stage-V renal disease or undergoing dialysis.
- Be suffering from a severe form of cardiovascular disease (NYHA Class III and IV)
Where it is running
- Mount Sinai Hospital — Chicago, Illinois, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.